Minimal Brain Dysfunction, Ritalin, and Racial Politics
This chapter examines psychologists’ involvement in the 1960s and 1970s in inventing a diagnosis known as “minimal brain dysfunction” (MBD) – a precursor to attention deficit attention disorder (ADHD). Although asserted to be a physiological matter, one best treated with stimulant drugs like methylphenidate (Ritalin), MBD was not based on a clear medical symptom. Quite soon, the modal individual for whom Ritalin became considered the most appropriate treatment was a white and middle-class child. As desegregation was often followed by the new phenomenon of tracking within schools, and as more African American children were labeled as suffering from “mild mental retardation,” the contrasting diagnosis of MBD represented a new disease entity to address the cognitive challenges sometimes faced by privileged children of the predominantly white suburbs. Simultaneously, a growing number of commentators, both African American and anti-racist white, came fiercely to protest what they perceived to be a disturbing tendency to overprescribe stimulant medications to poor children of color.